European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic …

J Dawson, Y Béjot, LM Christensen… - European stroke …, 2022 - journals.sagepub.com
Recurrent stroke affects 9% to 15% of people within 1 year. This European Stroke
Organisation (ESO) guideline provides evidence-based recommendations on …

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High …

P Urban, R Mehran, R Colleran, DJ Angiolillo… - Circulation, 2019 - Am Heart Assoc
Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …

2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing …

DJ Kumbhani, CP Cannon, CJ Beavers… - Journal of the American …, 2021 - jacc.org
The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

P Kirchhof, S Benussi, D Kotecha… - Polish Heart …, 2016 - journals.viamedica.pl
Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …

[HTML][HTML] Prevention of bleeding in patients with atrial fibrillation undergoing PCI

CM Gibson, R Mehran, C Bode… - … England Journal of …, 2016 - Mass Medical Soc
Background In patients with atrial fibrillation undergoing percutaneous coronary intervention
(PCI) with placement of stents, standard anticoagulation with a vitamin K antagonist plus …

Atualização da diretriz de ressuscitação cardiopulmonar e cuidados cardiovasculares de emergência da Sociedade Brasileira de Cardiologia-2019

C Bernoche, S Timerman, TF Polastri… - Arquivos brasileiros de …, 2019 - SciELO Brasil
A doença cardíaca isquêmica, principal determinante da PCR, continua liderando as
causas de morte no mundo, e no Brasil não é diferente. 1, 2 Em 2013, nos Estados Unidos …

[PDF][PDF] 2014 ESC/EACTS Guidelines on myocardial revascularization

S Windecker, P Kolh, F Alfonso… - Kardiologia Polska …, 2014 - journals.viamedica.pl
Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

R Mehran, SV Rao, DL Bhatt, CM Gibson, A Caixeta… - Circulation, 2011 - Am Heart Assoc
Advances in antithrombotic therapy, along with an early invasive strategy, have reduced the
incidence of recurrent ischemic events and death in patients with acute coronary syndromes …

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …

Authors/Task Force Members, CW Hamm… - European heart …, 2011 - academic.oup.com
ESC Guidelines 3002 recommendations. To implement the guidelines, condensed pocket
guidelines versions, summary slides, booklets with essential messages, and an electronic …

[HTML][HTML] Rivaroxaban in patients with a recent acute coronary syndrome

JL Mega, E Braunwald, SD Wiviott… - … England Journal of …, 2012 - Mass Medical Soc
Background Acute coronary syndromes arise from coronary atherosclerosis with
superimposed thrombosis. Since factor Xa plays a central role in thrombosis, the inhibition of …